• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064

• Other Chemical Reagents Organic Metal Reagents

Research Briefing on Magnesium,bromo[(3-bromophenyl)methyl]- (CAS: 107549-22-4) in Chemical Biology and Pharmaceutical Applications

Magnesium,bromo[(3-bromophenyl)methyl]-, with the CAS number 107549-22-4, is a specialized organomagnesium compound that has garnered attention in recent chemical biology and pharmaceutical research. This compound, characterized by its unique brominated phenylmethyl structure, has shown potential in various applications, including catalysis, medicinal chemistry, and material science. The presence of both magnesium and bromine functionalities offers distinct reactivity profiles, making it a valuable intermediate in synthetic chemistry and drug discovery.

Recent studies have focused on the synthesis and characterization of Magnesium,bromo[(3-bromophenyl)methyl]- to explore its utility in cross-coupling reactions, a cornerstone of modern organic synthesis. Researchers have reported its efficacy in facilitating carbon-carbon bond formations under mild conditions, which is critical for the construction of complex pharmaceutical scaffolds. Additionally, its role as a Grignard reagent analog has been investigated, highlighting its potential to replace traditional reagents in certain transformations, thereby improving yield and selectivity.

In the context of medicinal chemistry, preliminary investigations suggest that derivatives of Magnesium,bromo[(3-bromophenyl)methyl]- may exhibit bioactivity against specific enzyme targets. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its inhibitory effects on kinases involved in inflammatory pathways, opening avenues for the development of novel anti-inflammatory agents. However, further in vitro and in vivo studies are required to validate these findings and assess the compound's pharmacokinetic properties.

The stability and handling of Magnesium,bromo[(3-bromophenyl)methyl]- under various conditions have also been a subject of research. Advances in protective group strategies and solvent systems have improved its shelf-life and reactivity, addressing earlier challenges related to its sensitivity to moisture and air. These developments are crucial for its scalable production and application in industrial settings.

Looking ahead, the integration of computational chemistry and high-throughput screening methods is expected to accelerate the exploration of Magnesium,bromo[(3-bromophenyl)methyl]-'s full potential. Collaborative efforts between academia and industry will be essential to translate these findings into practical solutions for drug development and other chemical applications. This briefing underscores the compound's promising trajectory and calls for continued investment in research to unlock its multifaceted capabilities.

• 92206-72-9(Magnesium, bromo[(4-bromophenyl)methyl]-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)